SCHEMBL6802675

SCHEMBL6802675

Cc1ccc(S(=O)(=O)C(Cc2ccc([N+](=O)[O-])cc2)(OC(N)=O)C(C)(C)C)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.46
ACHE P22303 2/20 0.44
BCHE P06276 1/20 0.44
PKM P14618 2/20 0.44
KMT2A Q03164 3/20 0.42
LMNA P02545 2/20 0.41
MEN1 O00255 2/20 0.41
GAA P10253 1/20 0.41
RAB9A P51151 2/20 0.40
HSD17B10 Q99714 1/20 0.40
ALDH1A1 P00352 3/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
THRB P10828 1/20 0.40
CYP2C9 P11712 1/20 0.40
HPGD P15428 1/20 0.40
CYP2C19 P33261 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
MMP1 P03956 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6831580 0.86 MAPT (0.35) MAPTKMT2ALMNAMEN1GAA
SCHEMBL6925782 0.82 GAA (0.43) MAPTKMT2AMEN1GAARAB9A
SCHEMBL7127284 0.79 MAPT (0.43) MAPTACHEBCHEPKMKMT2A
SCHEMBL6544963 0.75 ACHE (0.49) MAPTACHEBCHEPKMKMT2A
SCHEMBL6926341 0.75 KMT2A (0.48) MAPTACHEBCHEPKMKMT2A
SCHEMBL6802681 0.73 PKM (0.44) MAPTACHEBCHEPKMKMT2A
SCHEMBL4238193 0.70 MEN1 (0.46) MAPTKMT2ALMNAMEN1RAB9A
SCHEMBL27518370 0.69 MAPT (0.50) MAPTKMT2ALMNAMEN1GAA
SCHEMBL27518369 0.69 MEN1 (0.44) MAPTKMT2ALMNAMEN1RAB9A
SCHEMBL9308189 0.68 LOXL2 (0.50) MAPTKMT2ALMNAMEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040167183-A1 Phenethylamino sulfamic acids THE PROCTER & GAMBLE COMPANY 2004-08-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040167183-A1 Phenethylamino sulfamic acids PTPRM, PTPRS, PTPRE MAPT 3227/4885ACHE 3939/4885BCHE 2824/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.